The Capital city healthcare congress brings together key decision-makers from healthcare policy, industry, medicine, nursing, science, and research, alongside representatives from statutory and private health insurance companies. The event features dedicated sessions on access to innovative pharmaceuticals, Germany's health technology assessment and pricing framework AMNOG, and the evolving landscape of clinical research across Germany and Europe.
Berlin
Ask for a Free trial and get access to the latest stories
Our coverage includes:
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
